Despite an improved HIV PrEP-to-need ratio from 2018 to 2021, PrEP use relative to need was lower in certain populations, ...

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year ...

Feb 6 (Reuters) - Contract research firm IQVIA Holdings (IQV.N), opens new tab beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare ...

Iqvia (IQV) announced a strategic collaboration with Nvidia (NVDA) to help realize the potential of AI in healthcare and life sciences. Discover outperforming stocks and invest smarter with Top ...

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — IQVIA Holdings Inc. (IQV) on Thursday reported fourth-quarter profit of $437 million. On a per-share basis, the Durham, North Carolina-based company ...

Barclays lowered the firm’s price target on Iqvia (IQV) to $235 from $255 and keeps an Overweight rating on the shares. The firm says the life science tools group will likely continue to work ...

RESEARCH TRIANGLE PARK, N.C., January 13, 2025--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence ...

Companies including Illumina (ILMN) and IQVIA (IQV) are currently using Nvidia technology. The tech giant said that its technology, such as AI processes, can accelerate clinical trials by reducing ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...